title: The human P2X7 receptor and its role in innate immunity.
abstract: The human P2X7 receptor is a two-transmembrane ionotropic receptor which has a ubiquitous distribution and is most highly expressed on immune cells. In macrophages and similar myeloid cells primed by lipopolysaccharide (LPS), activation of P2X7 by extracellular ATP opens a cation channel/pore allowing massive K+ efflux associated with processing and secretion of pro-inflammatory cytokines interleukin (IL)-1β and IL-18. A variety of other downstream effects follows P2X7 activation over several minutes including shedding of certain surface molecules, membrane blebbing, microvesicle/exosome release and apoptosis of the cell. High concentrations of ATP (>100 µM) are required to activate P2X7 but it remains unclear where these levels exist, other than in inflammatory foci or confined spaces such as in bone. A variety of potent selective antagonists of P2X7 activation have recently become available, allowing clinical trials to be undertaken in inflammatory and immune-mediated disorders. Proteomic studies have shown that P2X7 exists as a large multiprotein complex which includes non-muscle myosin heavy chain and other elements of the cytoskeleton. In the absence of its ATP ligand and serum, P2X7 has an alternate function in the recognition and phagocytosis of non-opsonized foreign particles, including bacteria and apoptotic cells. The P2RX7 gene has many polymorphic variants and isoforms which increase or decrease function of the receptor. Genetic association studies have linked loss-of-function polymorphisms with reactivation of latent tuberculosis as well as symptomatic infection with certain other obligate intracellular pathogens. The many roles involving P2X7 suggest that this receptor is essential to fundamental aspects of the innate immune response.
authors: Ion Channels and Disease Section, Florey Neuroscience Institutes, University of Melbourne, Parkville, Victoria, Australia. james.wiley@florey.edu.au
authors: J S
authors: JS
authors: Wiley
authors: R
authors: R
authors: Sluyter
authors: B J
authors: BJ
authors: Gu
authors: L
authors: L
authors: Stokes
authors: S J
authors: SJ
authors: Fuller
mesh_terms: D017209:Apoptosis; D006801:Humans; D007113:Immunity, Innate; D007375:Interleukin-1 / Q000276:immunology / Q000378:metabolism; D010587:Phagocytosis; D040901:Proteomics; D018048:Receptors, Purinergic P2 / Q000378:metabolism; D058486:Receptors, Purinergic P2X7 / Q000235:genetics / Q000276:immunology* / Q000378:metabolism*
chemical_list: D007375:Interleukin-1; D018048:Receptors, Purinergic P2; D058486:Receptors, Purinergic P2X7